Literature DB >> 8492007

Sex hormones and headache.

S D Silberstein, G R Merriam.   

Abstract

A variety of evidence suggests a link between migraine and the female sex hormones. Women with migraine outnumber men by at least a 2:1 ratio and definite patterns of development and attacks are noted at menarche and throughout the period of menses, related to trimester of pregnancy, and again at menopause, although it may also regress. Hormonal replacement with estrogen can exacerbate migraine; oral contraceptives can change the character and frequency of migraine headache. This article will cover approaches to the therapy of hormone-related headaches associated with the menstrual cycle, menopause, and oral contraceptives.

Entities:  

Keywords:  Biology; Contraception; Contraceptive Methods; Diseases; Endocrine Effects; Endocrine System; Estrogens; Family Planning; Headache; Hormones; Menopause; Menstrual Cycle; Menstruation; Migraine; Oral Contraceptives; Physiology; Pituitary Hormones; Progestational Hormones; Progesterone; Prolactin; Prostaglandins; Reproduction; Signs And Symptoms; Treatment; Vascular Diseases

Mesh:

Substances:

Year:  1993        PMID: 8492007     DOI: 10.1016/0885-3924(93)90107-7

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  17 in total

1.  Menstrual migraine: update on pathophysiology and approach to therapy and management.

Authors:  Anne H Calhoun
Journal:  Curr Treat Options Neurol       Date:  2012-02       Impact factor: 3.598

2.  An Exploratory Study to Determine the Relationship between Cervical Dysfunction and Perimenstrual Migraines.

Authors:  Simone Horwitz; Aimee Stewart
Journal:  Physiother Can       Date:  2015       Impact factor: 1.037

3.  Precipitating and relieving factors of migraine headache in 200 iraqi kurdish patients.

Authors:  Ehsan K Al-Shimmery
Journal:  Oman Med J       Date:  2010-07

Review 4.  Sex differences in pain: a brief review of clinical and experimental findings.

Authors:  E J Bartley; R B Fillingim
Journal:  Br J Anaesth       Date:  2013-07       Impact factor: 9.166

5.  Neurological symptoms in individuals with fibrodysplasia ossificans progressiva.

Authors:  Joseph A Kitterman; Jonathan B Strober; Lixin Kan; David M Rocke; Amanda Cali; Jeannie Peeper; Jennifer Snow; Patricia L R Delai; Rolf Morhart; Robert J Pignolo; Eileen M Shore; Frederick S Kaplan
Journal:  J Neurol       Date:  2012-06-30       Impact factor: 4.849

Review 6.  Migraine in pregnancy: what are the safest treatment options?

Authors:  V Pfaffenrath; M Rehm
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

Review 7.  Estrogen, migraine, and vascular risk.

Authors:  Gianni Allais; Giulia Chiarle; Silvia Sinigaglia; Gisella Airola; Paola Schiapparelli; Chiara Benedetto
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

8.  Relationship between high prolactin levels and migraine attacks in patients with microprolactinoma.

Authors:  D Bosco; A Belfiore; A Fava; M De Rose; M Plastino; C Ceccotti; P Mungari; R Iannacchero; A Lavano
Journal:  J Headache Pain       Date:  2008-02-07       Impact factor: 7.277

9.  The prevalence and burden of recurrent headache in Australian adolescents: findings from the longitudinal study of Australian children.

Authors:  Margot J Wilkes; M Dilani Mendis; Leanne Bisset; Felix T Leung; Christopher T Sexton; Julie A Hides
Journal:  J Headache Pain       Date:  2021-06-01       Impact factor: 7.277

Review 10.  Preventative treatment of menstrual migraine.

Authors:  Christine L Lay; Susan W Broner
Journal:  Curr Pain Headache Rep       Date:  2007-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.